Analyst Ratings for Pear Therapeutics (PEAR)

PEAR Rating Summary

  |   Expand Research on PEAR
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/20/2023 Chardan Keay Nakae Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.39
(0.03)		 -92.31% Details
3/20/2023 TD Cowen Charles Rhyee Downgrade Hold
(Buy)		 N/A
(N/A)		 0.39
(0.03)		 -92.31% Details